Castration-resistant Prostate Cancer

• FDA label_change · 2018-08-31
  FDA Approved: XOFIGO — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA supplemental application for XOFIGO (radium-223 dichloride) submitted by Bayer HealthCare Pharmaceuticals Inc. to support changes to the…

• FDA label_change · 2016-05-27
  FDA Approved: JEVTANA — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approved a supplemental application for JEVTANA (cabazitaxel) submitted by Sanofi-Aventis U.S. LLC.

• FDA label_change · 2015-12-10
  FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)

  The FDA granted a supplemental application for ZYTIGA (abiraterone acetate) to update its labeling, expanding or modifying its approved indi…

• FDA label_change · 2015-01-05
  FDA Approved: JEVTANA — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approved a supplemental application for JEVTANA (cabazitaxel) filed by Sanofi-Aventis U.S. LLC, resulting in changes to its labeling.

• FDA label_change · 2012-07-03
  FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)

  The FDA approved a supplemental application for ZYTIGA (abiraterone acetate) submitted by Janssen Biotech, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.